Market size of Interventional Cardiology is a > 20B $US/year with a a CAGR of 7-8%
Objectives:
1- US & OUS Market launch of a novel concept of dual artery hemostasis, Terry2 for approach (market size 2023 255M)
2- 510k of ultra low profile delivery catheter for interventional cardiology (class 2) (Market size 500M)
3- R&D for a novel concept of biodegradable metallic stent (Fe/316L SS), pre-clinical testing for FIM in Q1 2026 (Coronary stent market size 10B, peripheral market stent size 5B)
Looking to raise 7M during Q1 2024 (Equity investment)
If interested, contact me :
[email protected] (Cell 418 4733325)
www.nanostent.ca